The content on this site is intended for healthcare professionals only
Adrienne Morgan talks to ecancer.tv about tissue donation and the way this benefits patients.
As an oncological researcher who contracted metastatic breast cancer, Ms Morgan explains the importance of clinical trials and emphasises the standard of care offered to patients who take part.
Real-world outcomes after post-Lu177 therapy in mCRPC show limited survival and heterogeneous treatment patterns
Adding durvalumab to neoadjuvant chemotherapy maintains quality of life in resectable NSCLC
Daratumumab, bortezomib/thalidomide/dexamethasone (D-VTd) and DARA maintenance shows benefit in transplant-eligible NDMM
Isatuximab plus lenalidomide and dexamethasone with bortezomib as a new standard of care for NDMM TI non-frail patients
Guiding transplant decisions in multiple myeloma with MRD
Laser oncosurgery - A new perspective in treating cancer
Choosing the right patients for transplant
ESMO 2024: Highlights and analysis
Head and Neck Cancers
